Semler Scientific (NASDAQ:SMLR) Posts Earnings Results, Beats Expectations By $0.35 EPS

Semler Scientific (NASDAQ:SMLR) announced its earnings results on Monday. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.35, Zacks reports. Semler Scientific had a net margin of 27.00% and a return on equity of 20.93%. The company had revenue of $13.51 million during the quarter.

Semler Scientific Stock Up 2.8 %

Shares of Semler Scientific stock traded up $1.11 during trading on Wednesday, hitting $40.11. 826,974 shares of the stock traded hands, compared to its average volume of 192,256. The stock has a market cap of $280.45 million, a price-to-earnings ratio of 19.57 and a beta of 0.92. Semler Scientific has a 52 week low of $20.88 and a 52 week high of $53.38. The firm’s fifty day moving average is $26.37 and its 200-day moving average is $28.81.

Insider Buying and Selling

In other Semler Scientific news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total transaction of $283,500.00. Following the transaction, the chief executive officer now directly owns 60,220 shares in the company, valued at $1,707,237. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 30.20% of the stock is currently owned by corporate insiders.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.